nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—Caffeine—CYP1B1—glaucoma	0.00336	1	CrCbGaD
Pentoxifylline—PDE5A—endothelium—glaucoma	0.00226	0.188	CbGeAlD
Pentoxifylline—NT5E—eye—glaucoma	0.00171	0.142	CbGeAlD
Pentoxifylline—NT5E—retina—glaucoma	0.00169	0.141	CbGeAlD
Pentoxifylline—NT5E—connective tissue—glaucoma	0.00165	0.137	CbGeAlD
Pentoxifylline—ADORA2B—eye—glaucoma	0.00146	0.121	CbGeAlD
Pentoxifylline—PDE5A—eye—glaucoma	0.00111	0.092	CbGeAlD
Pentoxifylline—PDE5A—retina—glaucoma	0.0011	0.0912	CbGeAlD
Pentoxifylline—PDE5A—connective tissue—glaucoma	0.00107	0.0887	CbGeAlD
Pentoxifylline—Feeling abnormal—Acetazolamide—glaucoma	0.000678	0.000895	CcSEcCtD
Pentoxifylline—Hypersensitivity—Apraclonidine—glaucoma	0.000677	0.000894	CcSEcCtD
Pentoxifylline—Nervousness—Clonidine—glaucoma	0.000677	0.000894	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000675	0.000891	CcSEcCtD
Pentoxifylline—Dyspnoea—Dorzolamide—glaucoma	0.000672	0.000887	CcSEcCtD
Pentoxifylline—Insomnia—Brinzolamide—glaucoma	0.00067	0.000885	CcSEcCtD
Pentoxifylline—Somnolence—Dorzolamide—glaucoma	0.00067	0.000885	CcSEcCtD
Pentoxifylline—Muscle spasms—Clonidine—glaucoma	0.00067	0.000885	CcSEcCtD
Pentoxifylline—Dyspnoea—Travoprost—glaucoma	0.000669	0.000883	CcSEcCtD
Pentoxifylline—Hypotension—Pilocarpine—glaucoma	0.000665	0.000879	CcSEcCtD
Pentoxifylline—Dyspepsia—Dorzolamide—glaucoma	0.000663	0.000876	CcSEcCtD
Pentoxifylline—Dyspnoea—Brinzolamide—glaucoma	0.000661	0.000872	CcSEcCtD
Pentoxifylline—Dyspepsia—Travoprost—glaucoma	0.00066	0.000872	CcSEcCtD
Pentoxifylline—Asthenia—Apraclonidine—glaucoma	0.000659	0.000871	CcSEcCtD
Pentoxifylline—Somnolence—Brinzolamide—glaucoma	0.000659	0.00087	CcSEcCtD
Pentoxifylline—Vision blurred—Clonidine—glaucoma	0.000657	0.000867	CcSEcCtD
Pentoxifylline—Decreased appetite—Dorzolamide—glaucoma	0.000655	0.000865	CcSEcCtD
Pentoxifylline—Urticaria—Acetazolamide—glaucoma	0.000653	0.000862	CcSEcCtD
Pentoxifylline—Tremor—Clonidine—glaucoma	0.000653	0.000862	CcSEcCtD
Pentoxifylline—Dyspepsia—Brinzolamide—glaucoma	0.000652	0.000861	CcSEcCtD
Pentoxifylline—Pruritus—Apraclonidine—glaucoma	0.00065	0.000859	CcSEcCtD
Pentoxifylline—Body temperature increased—Acetazolamide—glaucoma	0.00065	0.000858	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000649	0.000857	CcSEcCtD
Pentoxifylline—Flushing—Betaxolol—glaucoma	0.000647	0.000854	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Clonidine—glaucoma	0.000646	0.000854	CcSEcCtD
Pentoxifylline—Insomnia—Pilocarpine—glaucoma	0.000644	0.00085	CcSEcCtD
Pentoxifylline—Decreased appetite—Brinzolamide—glaucoma	0.000644	0.00085	CcSEcCtD
Pentoxifylline—Constipation—Travoprost—glaucoma	0.000642	0.000847	CcSEcCtD
Pentoxifylline—Agitation—Clonidine—glaucoma	0.00064	0.000845	CcSEcCtD
Pentoxifylline—Asthenia—Bimatoprost—glaucoma	0.000639	0.000844	CcSEcCtD
Pentoxifylline—Angioedema—Clonidine—glaucoma	0.000637	0.000841	CcSEcCtD
Pentoxifylline—Dyspnoea—Pilocarpine—glaucoma	0.000635	0.000838	CcSEcCtD
Pentoxifylline—Somnolence—Pilocarpine—glaucoma	0.000633	0.000836	CcSEcCtD
Pentoxifylline—Pruritus—Bimatoprost—glaucoma	0.00063	0.000833	CcSEcCtD
Pentoxifylline—Immune system disorder—Betaxolol—glaucoma	0.000629	0.000831	CcSEcCtD
Pentoxifylline—Diarrhoea—Apraclonidine—glaucoma	0.000629	0.00083	CcSEcCtD
Pentoxifylline—Malaise—Clonidine—glaucoma	0.000628	0.00083	CcSEcCtD
Pentoxifylline—Dyspepsia—Pilocarpine—glaucoma	0.000627	0.000828	CcSEcCtD
Pentoxifylline—Arrhythmia—Betaxolol—glaucoma	0.000622	0.000822	CcSEcCtD
Pentoxifylline—Feeling abnormal—Dorzolamide—glaucoma	0.000621	0.00082	CcSEcCtD
Pentoxifylline—Decreased appetite—Pilocarpine—glaucoma	0.000619	0.000817	CcSEcCtD
Pentoxifylline—Feeling abnormal—Travoprost—glaucoma	0.000618	0.000816	CcSEcCtD
Pentoxifylline—Conjunctivitis—Timolol—glaucoma	0.000616	0.000814	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Dorzolamide—glaucoma	0.000616	0.000814	CcSEcCtD
Pentoxifylline—Palpitations—Clonidine—glaucoma	0.000616	0.000813	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Travoprost—glaucoma	0.000614	0.00081	CcSEcCtD
Pentoxifylline—Feeling abnormal—Brinzolamide—glaucoma	0.000611	0.000806	CcSEcCtD
Pentoxifylline—Constipation—Pilocarpine—glaucoma	0.000609	0.000804	CcSEcCtD
Pentoxifylline—Sweating—Timolol—glaucoma	0.000608	0.000803	CcSEcCtD
Pentoxifylline—Dizziness—Apraclonidine—glaucoma	0.000608	0.000803	CcSEcCtD
Pentoxifylline—Erythema—Betaxolol—glaucoma	0.000607	0.000801	CcSEcCtD
Pentoxifylline—Urticaria—Dorzolamide—glaucoma	0.000599	0.000791	CcSEcCtD
Pentoxifylline—Epistaxis—Timolol—glaucoma	0.000598	0.00079	CcSEcCtD
Pentoxifylline—Abdominal pain—Dorzolamide—glaucoma	0.000596	0.000787	CcSEcCtD
Pentoxifylline—Body temperature increased—Dorzolamide—glaucoma	0.000596	0.000787	CcSEcCtD
Pentoxifylline—Tension—Betaxolol—glaucoma	0.000595	0.000786	CcSEcCtD
Pentoxifylline—Dysgeusia—Betaxolol—glaucoma	0.000594	0.000784	CcSEcCtD
Pentoxifylline—Chest pain—Clonidine—glaucoma	0.000593	0.000783	CcSEcCtD
Pentoxifylline—Abdominal pain—Travoprost—glaucoma	0.000593	0.000783	CcSEcCtD
Pentoxifylline—Anxiety—Clonidine—glaucoma	0.000591	0.000781	CcSEcCtD
Pentoxifylline—Asthenia—Acetazolamide—glaucoma	0.00059	0.000779	CcSEcCtD
Pentoxifylline—Dizziness—Bimatoprost—glaucoma	0.000589	0.000778	CcSEcCtD
Pentoxifylline—Nervousness—Betaxolol—glaucoma	0.000589	0.000778	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000589	0.000778	CcSEcCtD
Pentoxifylline—Urticaria—Brinzolamide—glaucoma	0.000589	0.000777	CcSEcCtD
Pentoxifylline—Feeling abnormal—Pilocarpine—glaucoma	0.000587	0.000775	CcSEcCtD
Pentoxifylline—Discomfort—Clonidine—glaucoma	0.000586	0.000774	CcSEcCtD
Pentoxifylline—Vomiting—Apraclonidine—glaucoma	0.000584	0.000772	CcSEcCtD
Pentoxifylline—Muscle spasms—Betaxolol—glaucoma	0.000583	0.00077	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Pilocarpine—glaucoma	0.000582	0.000769	CcSEcCtD
Pentoxifylline—Hypersensitivity—Brimonidine—glaucoma	0.000581	0.000768	CcSEcCtD
Pentoxifylline—Dry mouth—Clonidine—glaucoma	0.00058	0.000766	CcSEcCtD
Pentoxifylline—Dermatitis—Apraclonidine—glaucoma	0.000579	0.000765	CcSEcCtD
Pentoxifylline—Headache—Apraclonidine—glaucoma	0.000576	0.00076	CcSEcCtD
Pentoxifylline—Confusional state—Clonidine—glaucoma	0.000573	0.000757	CcSEcCtD
Pentoxifylline—Vision blurred—Betaxolol—glaucoma	0.000572	0.000755	CcSEcCtD
Pentoxifylline—Oedema—Clonidine—glaucoma	0.000569	0.000751	CcSEcCtD
Pentoxifylline—Tremor—Betaxolol—glaucoma	0.000568	0.00075	CcSEcCtD
Pentoxifylline—Asthenia—Brimonidine—glaucoma	0.000566	0.000748	CcSEcCtD
Pentoxifylline—Infection—Clonidine—glaucoma	0.000565	0.000746	CcSEcCtD
Pentoxifylline—Abdominal pain—Pilocarpine—glaucoma	0.000563	0.000743	CcSEcCtD
Pentoxifylline—Body temperature increased—Pilocarpine—glaucoma	0.000563	0.000743	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Betaxolol—glaucoma	0.000563	0.000743	CcSEcCtD
Pentoxifylline—Diarrhoea—Acetazolamide—glaucoma	0.000563	0.000743	CcSEcCtD
Pentoxifylline—Rash—Bimatoprost—glaucoma	0.000562	0.000742	CcSEcCtD
Pentoxifylline—Dermatitis—Bimatoprost—glaucoma	0.000561	0.000741	CcSEcCtD
Pentoxifylline—Anaemia—Betaxolol—glaucoma	0.000561	0.00074	CcSEcCtD
Pentoxifylline—Shock—Clonidine—glaucoma	0.000559	0.000739	CcSEcCtD
Pentoxifylline—Pruritus—Brimonidine—glaucoma	0.000558	0.000737	CcSEcCtD
Pentoxifylline—Headache—Bimatoprost—glaucoma	0.000558	0.000737	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Clonidine—glaucoma	0.000557	0.000735	CcSEcCtD
Pentoxifylline—Hypersensitivity—Dorzolamide—glaucoma	0.000555	0.000733	CcSEcCtD
Pentoxifylline—Tachycardia—Clonidine—glaucoma	0.000555	0.000733	CcSEcCtD
Pentoxifylline—Hypersensitivity—Travoprost—glaucoma	0.000553	0.00073	CcSEcCtD
Pentoxifylline—Skin disorder—Clonidine—glaucoma	0.000552	0.000729	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Clonidine—glaucoma	0.00055	0.000726	CcSEcCtD
Pentoxifylline—Malaise—Betaxolol—glaucoma	0.000547	0.000722	CcSEcCtD
Pentoxifylline—Nausea—Apraclonidine—glaucoma	0.000546	0.000721	CcSEcCtD
Pentoxifylline—Hypersensitivity—Brinzolamide—glaucoma	0.000546	0.000721	CcSEcCtD
Pentoxifylline—Dizziness—Acetazolamide—glaucoma	0.000544	0.000718	CcSEcCtD
Pentoxifylline—Anorexia—Clonidine—glaucoma	0.000542	0.000716	CcSEcCtD
Pentoxifylline—Asthenia—Dorzolamide—glaucoma	0.000541	0.000714	CcSEcCtD
Pentoxifylline—Asthenia—Travoprost—glaucoma	0.000538	0.000711	CcSEcCtD
Pentoxifylline—Palpitations—Betaxolol—glaucoma	0.000536	0.000708	CcSEcCtD
Pentoxifylline—Pruritus—Dorzolamide—glaucoma	0.000533	0.000704	CcSEcCtD
Pentoxifylline—Asthenia—Brinzolamide—glaucoma	0.000532	0.000702	CcSEcCtD
Pentoxifylline—Hypotension—Clonidine—glaucoma	0.000531	0.000702	CcSEcCtD
Pentoxifylline—Pruritus—Travoprost—glaucoma	0.000531	0.000701	CcSEcCtD
Pentoxifylline—PDE4A—GPCR downstream signaling—PTGFR—glaucoma	0.00053	0.00233	CbGpPWpGaD
Pentoxifylline—Nausea—Bimatoprost—glaucoma	0.000529	0.000699	CcSEcCtD
Pentoxifylline—Hypersensitivity—Pilocarpine—glaucoma	0.000525	0.000693	CcSEcCtD
Pentoxifylline—Pruritus—Brinzolamide—glaucoma	0.000524	0.000692	CcSEcCtD
Pentoxifylline—Vomiting—Acetazolamide—glaucoma	0.000523	0.00069	CcSEcCtD
Pentoxifylline—Dizziness—Brimonidine—glaucoma	0.000522	0.000689	CcSEcCtD
Pentoxifylline—ADORA2B—GPCR ligand binding—SMO—glaucoma	0.000521	0.00229	CbGpPWpGaD
Pentoxifylline—Musculoskeletal discomfort—Clonidine—glaucoma	0.000518	0.000684	CcSEcCtD
Pentoxifylline—Myalgia—Betaxolol—glaucoma	0.000516	0.000682	CcSEcCtD
Pentoxifylline—Chest pain—Betaxolol—glaucoma	0.000516	0.000682	CcSEcCtD
Pentoxifylline—Diarrhoea—Dorzolamide—glaucoma	0.000516	0.000681	CcSEcCtD
Pentoxifylline—Headache—Acetazolamide—glaucoma	0.000515	0.00068	CcSEcCtD
Pentoxifylline—Anxiety—Betaxolol—glaucoma	0.000515	0.00068	CcSEcCtD
Pentoxifylline—Insomnia—Clonidine—glaucoma	0.000514	0.000679	CcSEcCtD
Pentoxifylline—Immune system disorder—Timolol—glaucoma	0.000514	0.000679	CcSEcCtD
Pentoxifylline—Diarrhoea—Travoprost—glaucoma	0.000513	0.000678	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000513	0.000677	CcSEcCtD
Pentoxifylline—Asthenia—Pilocarpine—glaucoma	0.000511	0.000675	CcSEcCtD
Pentoxifylline—Discomfort—Betaxolol—glaucoma	0.00051	0.000674	CcSEcCtD
Pentoxifylline—Arrhythmia—Timolol—glaucoma	0.000509	0.000672	CcSEcCtD
Pentoxifylline—PDE5A—Hemostasis—SOD1—glaucoma	0.000507	0.00223	CbGpPWpGaD
Pentoxifylline—Dyspnoea—Clonidine—glaucoma	0.000507	0.000669	CcSEcCtD
Pentoxifylline—Diarrhoea—Brinzolamide—glaucoma	0.000507	0.000669	CcSEcCtD
Pentoxifylline—Somnolence—Clonidine—glaucoma	0.000506	0.000668	CcSEcCtD
Pentoxifylline—Dry mouth—Betaxolol—glaucoma	0.000505	0.000667	CcSEcCtD
Pentoxifylline—Pruritus—Pilocarpine—glaucoma	0.000504	0.000665	CcSEcCtD
Pentoxifylline—ADORA2A—Circadian rythm related genes—NGFR—glaucoma	0.000502	0.00221	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—LRP12—glaucoma	0.000502	0.00221	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—OPN4—glaucoma	0.000501	0.0022	CbGpPWpGaD
Pentoxifylline—Confusional state—Betaxolol—glaucoma	0.000499	0.000659	CcSEcCtD
Pentoxifylline—Dizziness—Dorzolamide—glaucoma	0.000498	0.000658	CcSEcCtD
Pentoxifylline—Rash—Brimonidine—glaucoma	0.000498	0.000657	CcSEcCtD
Pentoxifylline—Dermatitis—Brimonidine—glaucoma	0.000497	0.000656	CcSEcCtD
Pentoxifylline—ADORA1—GPCR downstream signaling—PTGFR—glaucoma	0.000497	0.00218	CbGpPWpGaD
Pentoxifylline—Dizziness—Travoprost—glaucoma	0.000496	0.000655	CcSEcCtD
Pentoxifylline—Erythema—Timolol—glaucoma	0.000496	0.000654	CcSEcCtD
Pentoxifylline—Oedema—Betaxolol—glaucoma	0.000495	0.000654	CcSEcCtD
Pentoxifylline—PDE4B—Signaling by GPCR—OPN4—glaucoma	0.000495	0.00218	CbGpPWpGaD
Pentoxifylline—Headache—Brimonidine—glaucoma	0.000494	0.000653	CcSEcCtD
Pentoxifylline—Decreased appetite—Clonidine—glaucoma	0.000494	0.000653	CcSEcCtD
Pentoxifylline—NT5E—Metabolism—TXN—glaucoma	0.000493	0.00217	CbGpPWpGaD
Pentoxifylline—Infection—Betaxolol—glaucoma	0.000492	0.000649	CcSEcCtD
Pentoxifylline—PDE4B—GPCR downstream signaling—PTGFR—glaucoma	0.000491	0.00216	CbGpPWpGaD
Pentoxifylline—Dizziness—Brinzolamide—glaucoma	0.00049	0.000647	CcSEcCtD
Pentoxifylline—Nausea—Acetazolamide—glaucoma	0.000488	0.000645	CcSEcCtD
Pentoxifylline—Diarrhoea—Pilocarpine—glaucoma	0.000487	0.000643	CcSEcCtD
Pentoxifylline—Shock—Betaxolol—glaucoma	0.000487	0.000643	CcSEcCtD
Pentoxifylline—Tension—Timolol—glaucoma	0.000486	0.000642	CcSEcCtD
Pentoxifylline—Constipation—Clonidine—glaucoma	0.000486	0.000642	CcSEcCtD
Pentoxifylline—Dysgeusia—Timolol—glaucoma	0.000485	0.000641	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Betaxolol—glaucoma	0.000485	0.00064	CcSEcCtD
Pentoxifylline—ADORA1—Circadian rythm related genes—FAS—glaucoma	0.000484	0.00213	CbGpPWpGaD
Pentoxifylline—Tachycardia—Betaxolol—glaucoma	0.000483	0.000638	CcSEcCtD
Pentoxifylline—PDE4A—Signaling by GPCR—PTGFR—glaucoma	0.000482	0.00212	CbGpPWpGaD
Pentoxifylline—Nervousness—Timolol—glaucoma	0.000481	0.000636	CcSEcCtD
Pentoxifylline—Skin disorder—Betaxolol—glaucoma	0.000481	0.000635	CcSEcCtD
Pentoxifylline—Vomiting—Dorzolamide—glaucoma	0.000479	0.000633	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Betaxolol—glaucoma	0.000479	0.000632	CcSEcCtD
Pentoxifylline—ADORA2A—Circadian rythm related genes—NTRK1—glaucoma	0.000477	0.0021	CbGpPWpGaD
Pentoxifylline—Rash—Dorzolamide—glaucoma	0.000475	0.000627	CcSEcCtD
Pentoxifylline—Dermatitis—Dorzolamide—glaucoma	0.000475	0.000627	CcSEcCtD
Pentoxifylline—Rash—Travoprost—glaucoma	0.000473	0.000625	CcSEcCtD
Pentoxifylline—Dermatitis—Travoprost—glaucoma	0.000473	0.000624	CcSEcCtD
Pentoxifylline—Headache—Dorzolamide—glaucoma	0.000472	0.000623	CcSEcCtD
Pentoxifylline—Anorexia—Betaxolol—glaucoma	0.000472	0.000623	CcSEcCtD
Pentoxifylline—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000471	0.00207	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000471	0.00207	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000471	0.00207	CbGpPWpGaD
Pentoxifylline—Vomiting—Brinzolamide—glaucoma	0.000471	0.000622	CcSEcCtD
Pentoxifylline—Dizziness—Pilocarpine—glaucoma	0.000471	0.000622	CcSEcCtD
Pentoxifylline—Headache—Travoprost—glaucoma	0.00047	0.000621	CcSEcCtD
Pentoxifylline—Nausea—Brimonidine—glaucoma	0.000469	0.000619	CcSEcCtD
Pentoxifylline—Feeling abnormal—Clonidine—glaucoma	0.000469	0.000619	CcSEcCtD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—NTRK1—glaucoma	0.000468	0.00206	CbGpPWpGaD
Pentoxifylline—Rash—Brinzolamide—glaucoma	0.000467	0.000617	CcSEcCtD
Pentoxifylline—Vision blurred—Timolol—glaucoma	0.000467	0.000617	CcSEcCtD
Pentoxifylline—Dermatitis—Brinzolamide—glaucoma	0.000467	0.000616	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Clonidine—glaucoma	0.000465	0.000614	CcSEcCtD
Pentoxifylline—Headache—Brinzolamide—glaucoma	0.000464	0.000613	CcSEcCtD
Pentoxifylline—Hypotension—Betaxolol—glaucoma	0.000463	0.000611	CcSEcCtD
Pentoxifylline—PDE4A—Signaling Pathways—LRP12—glaucoma	0.000456	0.00201	CbGpPWpGaD
Pentoxifylline—Angioedema—Timolol—glaucoma	0.000453	0.000598	CcSEcCtD
Pentoxifylline—Vomiting—Pilocarpine—glaucoma	0.000453	0.000598	CcSEcCtD
Pentoxifylline—Urticaria—Clonidine—glaucoma	0.000452	0.000597	CcSEcCtD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000451	0.00198	CbGpPWpGaD
Pentoxifylline—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000451	0.000596	CcSEcCtD
Pentoxifylline—ADORA1—Signaling by GPCR—PTGFR—glaucoma	0.000451	0.00198	CbGpPWpGaD
Pentoxifylline—Abdominal pain—Clonidine—glaucoma	0.00045	0.000594	CcSEcCtD
Pentoxifylline—Body temperature increased—Clonidine—glaucoma	0.00045	0.000594	CcSEcCtD
Pentoxifylline—Rash—Pilocarpine—glaucoma	0.000449	0.000593	CcSEcCtD
Pentoxifylline—Dermatitis—Pilocarpine—glaucoma	0.000449	0.000592	CcSEcCtD
Pentoxifylline—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000448	0.00197	CbGpPWpGaD
Pentoxifylline—Insomnia—Betaxolol—glaucoma	0.000448	0.000591	CcSEcCtD
Pentoxifylline—Nausea—Dorzolamide—glaucoma	0.000448	0.000591	CcSEcCtD
Pentoxifylline—Headache—Pilocarpine—glaucoma	0.000446	0.000589	CcSEcCtD
Pentoxifylline—Nausea—Travoprost—glaucoma	0.000446	0.000589	CcSEcCtD
Pentoxifylline—PDE4B—Signaling by GPCR—PTGFR—glaucoma	0.000446	0.00196	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—SMO—glaucoma	0.000443	0.00195	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—NTRK2—glaucoma	0.000442	0.00194	CbGpPWpGaD
Pentoxifylline—Dyspnoea—Betaxolol—glaucoma	0.000441	0.000583	CcSEcCtD
Pentoxifylline—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000441	0.00194	CbGpPWpGaD
Pentoxifylline—Nausea—Brinzolamide—glaucoma	0.00044	0.000581	CcSEcCtD
Pentoxifylline—Palpitations—Timolol—glaucoma	0.000438	0.000578	CcSEcCtD
Pentoxifylline—Dyspepsia—Betaxolol—glaucoma	0.000436	0.000575	CcSEcCtD
Pentoxifylline—Decreased appetite—Betaxolol—glaucoma	0.00043	0.000568	CcSEcCtD
Pentoxifylline—Hypertension—Timolol—glaucoma	0.000428	0.000565	CcSEcCtD
Pentoxifylline—ADORA1—Signaling Pathways—LRP12—glaucoma	0.000427	0.00188	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—OPN4—glaucoma	0.000426	0.00187	CbGpPWpGaD
Pentoxifylline—Constipation—Betaxolol—glaucoma	0.000423	0.000559	CcSEcCtD
Pentoxifylline—Nausea—Pilocarpine—glaucoma	0.000423	0.000559	CcSEcCtD
Pentoxifylline—Chest pain—Timolol—glaucoma	0.000422	0.000557	CcSEcCtD
Pentoxifylline—Myalgia—Timolol—glaucoma	0.000422	0.000557	CcSEcCtD
Pentoxifylline—PDE4B—Signaling Pathways—LRP12—glaucoma	0.000422	0.00186	CbGpPWpGaD
Pentoxifylline—ADORA1—G alpha (i) signalling events—C3—glaucoma	0.000421	0.00185	CbGpPWpGaD
Pentoxifylline—Anxiety—Timolol—glaucoma	0.00042	0.000555	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000419	0.000553	CcSEcCtD
Pentoxifylline—Hypersensitivity—Clonidine—glaucoma	0.000419	0.000553	CcSEcCtD
Pentoxifylline—Discomfort—Timolol—glaucoma	0.000417	0.00055	CcSEcCtD
Pentoxifylline—Dry mouth—Timolol—glaucoma	0.000413	0.000545	CcSEcCtD
Pentoxifylline—Asthenia—Clonidine—glaucoma	0.000408	0.000539	CcSEcCtD
Pentoxifylline—Feeling abnormal—Betaxolol—glaucoma	0.000408	0.000539	CcSEcCtD
Pentoxifylline—Confusional state—Timolol—glaucoma	0.000408	0.000538	CcSEcCtD
Pentoxifylline—PDE4B—Myometrial Relaxation and Contraction Pathways—NOS3—glaucoma	0.000405	0.00178	CbGpPWpGaD
Pentoxifylline—Oedema—Timolol—glaucoma	0.000404	0.000534	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Timolol—glaucoma	0.000404	0.000534	CcSEcCtD
Pentoxifylline—Pruritus—Clonidine—glaucoma	0.000402	0.000531	CcSEcCtD
Pentoxifylline—Infection—Timolol—glaucoma	0.000402	0.000531	CcSEcCtD
Pentoxifylline—Shock—Timolol—glaucoma	0.000398	0.000525	CcSEcCtD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000394	0.00173	CbGpPWpGaD
Pentoxifylline—Urticaria—Betaxolol—glaucoma	0.000393	0.000519	CcSEcCtD
Pentoxifylline—Skin disorder—Timolol—glaucoma	0.000393	0.000519	CcSEcCtD
Pentoxifylline—Body temperature increased—Betaxolol—glaucoma	0.000391	0.000517	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Timolol—glaucoma	0.000391	0.000516	CcSEcCtD
Pentoxifylline—Diarrhoea—Clonidine—glaucoma	0.000389	0.000514	CcSEcCtD
Pentoxifylline—PDE5A—Hemostasis—MMP1—glaucoma	0.000387	0.0017	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—OPN4—glaucoma	0.000387	0.0017	CbGpPWpGaD
Pentoxifylline—Anorexia—Timolol—glaucoma	0.000386	0.000509	CcSEcCtD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000384	0.00169	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PTGFR—glaucoma	0.000383	0.00169	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—GSTT1—glaucoma	0.000382	0.00168	CbGpPWpGaD
Pentoxifylline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000381	0.00168	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—NGF—glaucoma	0.00038	0.00167	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—NGFR—glaucoma	0.000379	0.00167	CbGpPWpGaD
Pentoxifylline—Hypotension—Timolol—glaucoma	0.000378	0.000499	CcSEcCtD
Pentoxifylline—Dizziness—Clonidine—glaucoma	0.000376	0.000497	CcSEcCtD
Pentoxifylline—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000376	0.00165	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—FAS—glaucoma	0.000374	0.00165	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—CAV1—glaucoma	0.000371	0.00163	CbGpPWpGaD
Pentoxifylline—Musculoskeletal discomfort—Timolol—glaucoma	0.000368	0.000487	CcSEcCtD
Pentoxifylline—Insomnia—Timolol—glaucoma	0.000366	0.000483	CcSEcCtD
Pentoxifylline—Hypersensitivity—Betaxolol—glaucoma	0.000365	0.000482	CcSEcCtD
Pentoxifylline—Vomiting—Clonidine—glaucoma	0.000362	0.000477	CcSEcCtD
Pentoxifylline—Dyspnoea—Timolol—glaucoma	0.000361	0.000476	CcSEcCtD
Pentoxifylline—ADORA2A—Signaling by NGF—NTRK1—glaucoma	0.00036	0.00158	CbGpPWpGaD
Pentoxifylline—Somnolence—Timolol—glaucoma	0.00036	0.000475	CcSEcCtD
Pentoxifylline—Rash—Clonidine—glaucoma	0.000359	0.000473	CcSEcCtD
Pentoxifylline—Dermatitis—Clonidine—glaucoma	0.000358	0.000473	CcSEcCtD
Pentoxifylline—Headache—Clonidine—glaucoma	0.000356	0.00047	CcSEcCtD
Pentoxifylline—Dyspepsia—Timolol—glaucoma	0.000356	0.00047	CcSEcCtD
Pentoxifylline—Asthenia—Betaxolol—glaucoma	0.000355	0.000469	CcSEcCtD
Pentoxifylline—PDE5A—Hemostasis—FN1—glaucoma	0.000353	0.00155	CbGpPWpGaD
Pentoxifylline—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.000352	0.00155	CbGpPWpGaD
Pentoxifylline—Decreased appetite—Timolol—glaucoma	0.000352	0.000464	CcSEcCtD
Pentoxifylline—Pruritus—Betaxolol—glaucoma	0.00035	0.000463	CcSEcCtD
Pentoxifylline—ADORA2A—Signaling by GPCR—PTGFR—glaucoma	0.000348	0.00153	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—OPN4—glaucoma	0.000348	0.00153	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—EDN1—glaucoma	0.000344	0.00151	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—SMO—glaucoma	0.000342	0.0015	CbGpPWpGaD
Pentoxifylline—Diarrhoea—Betaxolol—glaucoma	0.000339	0.000447	CcSEcCtD
Pentoxifylline—Nausea—Clonidine—glaucoma	0.000338	0.000446	CcSEcCtD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000335	0.00147	CbGpPWpGaD
Pentoxifylline—Feeling abnormal—Timolol—glaucoma	0.000333	0.00044	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Timolol—glaucoma	0.000331	0.000437	CcSEcCtD
Pentoxifylline—ADORA2A—Signaling Pathways—LRP12—glaucoma	0.00033	0.00145	CbGpPWpGaD
Pentoxifylline—Dizziness—Betaxolol—glaucoma	0.000327	0.000432	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling Pathways—HEYL—glaucoma	0.000323	0.00142	CbGpPWpGaD
Pentoxifylline—Urticaria—Timolol—glaucoma	0.000321	0.000424	CcSEcCtD
Pentoxifylline—Body temperature increased—Timolol—glaucoma	0.00032	0.000422	CcSEcCtD
Pentoxifylline—Abdominal pain—Timolol—glaucoma	0.00032	0.000422	CcSEcCtD
Pentoxifylline—PDE4A—Signaling Pathways—OPN4—glaucoma	0.000316	0.00139	CbGpPWpGaD
Pentoxifylline—Vomiting—Betaxolol—glaucoma	0.000315	0.000416	CcSEcCtD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—BAD—glaucoma	0.000314	0.00138	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PTGFR—glaucoma	0.000313	0.00138	CbGpPWpGaD
Pentoxifylline—Rash—Betaxolol—glaucoma	0.000312	0.000412	CcSEcCtD
Pentoxifylline—Dermatitis—Betaxolol—glaucoma	0.000312	0.000412	CcSEcCtD
Pentoxifylline—Headache—Betaxolol—glaucoma	0.00031	0.00041	CcSEcCtD
Pentoxifylline—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000309	0.00136	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—ABCA1—glaucoma	0.000305	0.00134	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—CYP1B1—glaucoma	0.000305	0.00134	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—C3—glaucoma	0.0003	0.00132	CbGpPWpGaD
Pentoxifylline—Hypersensitivity—Timolol—glaucoma	0.000298	0.000393	CcSEcCtD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000296	0.0013	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—OPN4—glaucoma	0.000296	0.0013	CbGpPWpGaD
Pentoxifylline—Nausea—Betaxolol—glaucoma	0.000294	0.000388	CcSEcCtD
Pentoxifylline—PDE4A—Signaling Pathways—HEYL—glaucoma	0.000294	0.00129	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—NGF—glaucoma	0.000293	0.00129	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—OPN4—glaucoma	0.000292	0.00129	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—EDN1—glaucoma	0.000292	0.00129	CbGpPWpGaD
Pentoxifylline—Asthenia—Timolol—glaucoma	0.00029	0.000383	CcSEcCtD
Pentoxifylline—Pruritus—Timolol—glaucoma	0.000286	0.000378	CcSEcCtD
Pentoxifylline—PDE4A—Signaling Pathways—PTGFR—glaucoma	0.000284	0.00125	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—NOS3—glaucoma	0.000281	0.00123	CbGpPWpGaD
Pentoxifylline—Diarrhoea—Timolol—glaucoma	0.000277	0.000365	CcSEcCtD
Pentoxifylline—ADORA1—Signaling Pathways—HEYL—glaucoma	0.000275	0.00121	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HEYL—glaucoma	0.000272	0.0012	CbGpPWpGaD
Pentoxifylline—Dizziness—Timolol—glaucoma	0.000267	0.000353	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling by GPCR—SMO—glaucoma	0.000267	0.00118	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PTGFR—glaucoma	0.000266	0.00117	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PTGFR—glaucoma	0.000263	0.00116	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000259	0.00114	CbGpPWpGaD
Pentoxifylline—Vomiting—Timolol—glaucoma	0.000257	0.00034	CcSEcCtD
Pentoxifylline—ADORA1—GPCR ligand binding—C3—glaucoma	0.000255	0.00112	CbGpPWpGaD
Pentoxifylline—Rash—Timolol—glaucoma	0.000255	0.000337	CcSEcCtD
Pentoxifylline—Dermatitis—Timolol—glaucoma	0.000255	0.000336	CcSEcCtD
Pentoxifylline—Headache—Timolol—glaucoma	0.000253	0.000335	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling Pathways—RPTOR—glaucoma	0.000245	0.00108	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—GSTM1—glaucoma	0.000243	0.00107	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—SMO—glaucoma	0.000243	0.00107	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—BAD—glaucoma	0.000241	0.00106	CbGpPWpGaD
Pentoxifylline—Nausea—Timolol—glaucoma	0.00024	0.000317	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling Pathways—NCK2—glaucoma	0.000237	0.00104	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—OPN4—glaucoma	0.000228	0.001	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—SMO—glaucoma	0.000227	0.001	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—EDN1—glaucoma	0.000226	0.000992	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—SMO—glaucoma	0.000225	0.000988	CbGpPWpGaD
Pentoxifylline—CYP1A2—Phase II conjugation—GSTM1—glaucoma	0.000224	0.000986	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RPTOR—glaucoma	0.000223	0.000979	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1B—glaucoma	0.000218	0.000961	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NCK2—glaucoma	0.000216	0.000948	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—MTHFR—glaucoma	0.000215	0.000947	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000212	0.000934	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HEYL—glaucoma	0.000212	0.000934	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RPTOR—glaucoma	0.000208	0.000917	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RPTOR—glaucoma	0.000206	0.000906	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—GSTT1—glaucoma	0.000206	0.000906	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTGFR—glaucoma	0.000206	0.000905	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—VEGFA—glaucoma	0.000202	0.000889	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NCK2—glaucoma	0.000202	0.000888	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HDAC9—glaucoma	0.000202	0.000888	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000201	0.000885	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000201	0.000885	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—APOE—glaucoma	0.0002	0.000881	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NCK2—glaucoma	0.000199	0.000878	CbGpPWpGaD
Pentoxifylline—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	0.000199	0.000874	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—CAV1—glaucoma	0.000198	0.000873	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—C3—glaucoma	0.000197	0.000867	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—EDN1—glaucoma	0.000194	0.000854	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HDAC9—glaucoma	0.000183	0.000806	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—TP53—glaucoma	0.000181	0.000798	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—EDN1—glaucoma	0.000176	0.000776	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—EDN1—glaucoma	0.000176	0.000776	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—SMO—glaucoma	0.000176	0.000772	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HDAC9—glaucoma	0.000172	0.000755	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HDAC9—glaucoma	0.00017	0.000746	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—C3—glaucoma	0.00017	0.000746	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—CDKN1B—glaucoma	0.000168	0.000739	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000167	0.000736	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—EDN1—glaucoma	0.000165	0.000726	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—CYP1B1—glaucoma	0.000164	0.000722	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—EDN1—glaucoma	0.000163	0.000718	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	0.000162	0.000712	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RPTOR—glaucoma	0.000161	0.000708	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—EDN1—glaucoma	0.00016	0.000704	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SMO—glaucoma	0.000158	0.000695	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NCK2—glaucoma	0.000156	0.000686	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—C3—glaucoma	0.000154	0.000678	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—C3—glaucoma	0.000154	0.000678	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000153	0.000674	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—TP53—glaucoma	0.000153	0.000672	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—NOS3—glaucoma	0.00015	0.00066	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—EDN1—glaucoma	0.00015	0.000659	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—EDN1—glaucoma	0.000148	0.000652	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NTRK2—glaucoma	0.000144	0.000636	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NARFL—glaucoma	0.000144	0.000635	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CA5A—glaucoma	0.000144	0.000635	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—C3—glaucoma	0.000144	0.000634	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SMO—glaucoma	0.000143	0.000631	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.000143	0.000631	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000143	0.000631	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—C3—glaucoma	0.000142	0.000627	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—TP53—glaucoma	0.00014	0.000616	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—C3—glaucoma	0.00014	0.000615	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PTGS2—glaucoma	0.000137	0.000604	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SMO—glaucoma	0.000134	0.000591	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SMO—glaucoma	0.000133	0.000584	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HDAC9—glaucoma	0.000133	0.000583	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NTRK2—glaucoma	0.000131	0.000577	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—GSTM1—glaucoma	0.000131	0.000577	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—C3—glaucoma	0.000131	0.000576	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—C3—glaucoma	0.000129	0.000569	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	0.000129	0.000569	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—EDN1—glaucoma	0.000127	0.000561	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NGFR—glaucoma	0.000124	0.000545	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NTRK2—glaucoma	0.000123	0.00054	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NTRK2—glaucoma	0.000121	0.000534	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NTRK1—glaucoma	0.000118	0.000518	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—EDN1—glaucoma	0.000116	0.000509	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NGFR—glaucoma	0.000113	0.000495	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—C3—glaucoma	0.000111	0.00049	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CDKN2B—glaucoma	0.000109	0.000477	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NTRK1—glaucoma	0.000107	0.00047	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NGFR—glaucoma	0.000105	0.000464	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NGFR—glaucoma	0.000104	0.000458	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EDN1—glaucoma	0.000104	0.000458	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SMO—glaucoma	0.000104	0.000456	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—C3—glaucoma	0.000101	0.000445	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NTRK1—glaucoma	0.0001	0.000441	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NTRK1—glaucoma	9.9e-05	0.000435	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CDKN2B—glaucoma	9.86e-05	0.000434	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NGF—glaucoma	9.57e-05	0.000421	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NTRK2—glaucoma	9.48e-05	0.000417	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EDN1—glaucoma	9.46e-05	0.000416	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CDKN2B—glaucoma	9.23e-05	0.000406	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CDKN2B—glaucoma	9.12e-05	0.000401	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—C3—glaucoma	9.1e-05	0.0004	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EDN1—glaucoma	8.86e-05	0.00039	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EDN1—glaucoma	8.75e-05	0.000385	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NGF—glaucoma	8.69e-05	0.000382	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APOE—glaucoma	8.47e-05	0.000373	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CAV1—glaucoma	8.39e-05	0.000369	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—C3—glaucoma	8.26e-05	0.000363	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NGF—glaucoma	8.14e-05	0.000358	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NGFR—glaucoma	8.14e-05	0.000358	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NGF—glaucoma	8.04e-05	0.000354	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FN1—glaucoma	7.99e-05	0.000351	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—BAD—glaucoma	7.89e-05	0.000347	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—C3—glaucoma	7.74e-05	0.00034	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NTRK1—glaucoma	7.73e-05	0.00034	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APOE—glaucoma	7.69e-05	0.000338	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—C3—glaucoma	7.64e-05	0.000336	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CAV1—glaucoma	7.62e-05	0.000335	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FN1—glaucoma	7.25e-05	0.000319	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APOE—glaucoma	7.2e-05	0.000317	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—BAD—glaucoma	7.17e-05	0.000315	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CAV1—glaucoma	7.14e-05	0.000314	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CDKN2B—glaucoma	7.13e-05	0.000313	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APOE—glaucoma	7.12e-05	0.000313	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CAV1—glaucoma	7.05e-05	0.00031	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CA1—glaucoma	7.05e-05	0.00031	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EDN1—glaucoma	6.84e-05	0.000301	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CTSA—glaucoma	6.83e-05	0.0003	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FN1—glaucoma	6.79e-05	0.000299	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—BAD—glaucoma	6.71e-05	0.000295	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FN1—glaucoma	6.71e-05	0.000295	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—BAD—glaucoma	6.63e-05	0.000292	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CA2—glaucoma	6.45e-05	0.000284	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NOS3—glaucoma	6.35e-05	0.000279	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.3e-05	0.000277	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.3e-05	0.000277	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NGF—glaucoma	6.28e-05	0.000276	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—C3—glaucoma	5.97e-05	0.000263	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NOS3—glaucoma	5.76e-05	0.000253	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APOE—glaucoma	5.56e-05	0.000245	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CAV1—glaucoma	5.51e-05	0.000242	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CDKN1B—glaucoma	5.5e-05	0.000242	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NOS3—glaucoma	5.4e-05	0.000237	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NOS3—glaucoma	5.33e-05	0.000235	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FN1—glaucoma	5.24e-05	0.000231	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—BAD—glaucoma	5.18e-05	0.000228	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MMP9—glaucoma	5.09e-05	0.000224	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CDKN1B—glaucoma	4.99e-05	0.00022	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CDKN1B—glaucoma	4.67e-05	0.000206	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MMP9—glaucoma	4.62e-05	0.000203	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CDKN1B—glaucoma	4.62e-05	0.000203	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VEGFA—glaucoma	4.57e-05	0.000201	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TXN—glaucoma	4.54e-05	0.0002	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MMP9—glaucoma	4.33e-05	0.00019	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MMP9—glaucoma	4.28e-05	0.000188	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NOS3—glaucoma	4.17e-05	0.000183	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VEGFA—glaucoma	4.15e-05	0.000183	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.14e-05	0.000182	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.11e-05	0.000181	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VEGFA—glaucoma	3.89e-05	0.000171	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VEGFA—glaucoma	3.84e-05	0.000169	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CDKN1B—glaucoma	3.61e-05	0.000159	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTT1—glaucoma	3.52e-05	0.000155	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TP53—glaucoma	3.45e-05	0.000152	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MMP9—glaucoma	3.34e-05	0.000147	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TP53—glaucoma	3.14e-05	0.000138	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VEGFA—glaucoma	3e-05	0.000132	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TP53—glaucoma	2.94e-05	0.000129	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TP53—glaucoma	2.9e-05	0.000128	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.84e-05	0.000125	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ABCA1—glaucoma	2.81e-05	0.000123	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP1B1—glaucoma	2.81e-05	0.000123	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TP53—glaucoma	2.27e-05	9.98e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTM1—glaucoma	2.24e-05	9.87e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MTHFR—glaucoma	1.98e-05	8.72e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—APOE—glaucoma	1.85e-05	8.12e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CAV1—glaucoma	1.83e-05	8.04e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NOS3—glaucoma	1.38e-05	6.08e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTGS2—glaucoma	1.26e-05	5.56e-05	CbGpPWpGaD
